ImmunoPrecise Antibodies Ltd

NASDAQ:IPA   10:51:41 AM EDT
-0.01 (-0.65%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)48.06M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$4.33 Million
Adjusted EPS-$0.10
See more estimates
10-Day MA$1.97
50-Day MA$2.18
200-Day MA$3.28
See more pivots

ImmunoPrecise Antibodies Ltd Stock, NASDAQ:IPA

4464 Markham Street, Suite 3204, Victoria, British Columbia V8Z 7X8
Phone: +1.250.483.0308
Number of Employees: 102


ImmunoPrecise Antibodies Ltd. is a therapeutic antibody discovery company, which engages in the provision of human therapeutic antibody discovery and development services. The firm offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Victoria, Canada.